发明授权
- 专利标题: Anaplastic lymphoma kinase modulators and methods of use
- 专利标题(中): 间变性淋巴瘤激酶调节剂及其使用方法
-
申请号: US10565657申请日: 2004-07-23
-
公开(公告)号: US07872014B2公开(公告)日: 2011-01-18
- 发明人: Neel Kumar Anand , Charles M. Blazey , Owen Joseph Bowles , Joerg Bussenius , Simona Costanzo , Jeffry Kimo Curtis , Larisa Dubenko , Abigail R. Kennedy , Richard G. Khoury , Angie I. Kim , Jean-Claire L. Manalo , Csaba J. Peto , Kenneth D. Rice , Tsze H. Tsang
- 申请人: Neel Kumar Anand , Charles M. Blazey , Owen Joseph Bowles , Joerg Bussenius , Simona Costanzo , Jeffry Kimo Curtis , Larisa Dubenko , Abigail R. Kennedy , Richard G. Khoury , Angie I. Kim , Jean-Claire L. Manalo , Csaba J. Peto , Kenneth D. Rice , Tsze H. Tsang
- 申请人地址: US CA South San Francisco
- 专利权人: Exelixis, Inc.
- 当前专利权人: Exelixis, Inc.
- 当前专利权人地址: US CA South San Francisco
- 代理机构: McDonnell Boehnen Hulbert & Berghoff LLP
- 国际申请: PCT/US2004/023762 WO 20040723
- 国际公布: WO2005/009389 WO 20050203
- 主分类号: C07D471/02
- IPC分类号: C07D471/02 ; A61K31/4745
摘要:
The present invention comprises compounds and pharmaceutical compositions comprising the compounds that are inhibitors of ALK. The invention also comprises methods of using the compounds and compositions to treat diseases mediated by ALK, including diseases such as cancer, immunological disorders, cardiovascular diseases, and other degenerative disorders.
公开/授权文献
- US20070032515A1 Anaplastic lymphoma kinase modulators and methods of use 公开/授权日:2007-02-08
信息查询